NCT01797081 - BOTOX® in the Treatment of Crow's Feet Lines in Japan | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 18, 2013

Study Completion Date

July 7, 2014

Conditions

Lateral Canthus RhytidesCrow's Feet Lines

Interventions

BIOLOGICAL

botulinum toxin Type A (24 U)

24 units botulinum toxin Type A (total dose) injected into bilateral Crow's Feet Line areas per treatment.

BIOLOGICAL

botulinum toxin Type A (12 U)

12 units botulinum toxin Type A (total dose) injected into bilateral Crow's Feet Line areas per treatment.

OTHER

Normal Saline

Normal saline (placebo) injected into bilateral Crow's Feet Line areas per treatment.

Trial Locations (1)

Tokyo